Progressive Supranuclear Palsy and Corticobasal Degeneration: Similarities and Differences Pratap Chand, MD, DM, FRCP; Irene Litvan, MD Disclosures Future Neurology. 2008;3 (3):299-307. 0 ...

The patient in this case presented with a subacute neurological decline characterized by symptoms that were suggestive of a prominent midbrain involvement (i.e. vertical gaze palsy and atypical ...

PSP is a degenerative disease that, like Parkinson's disease, causes symptoms such as gait disturbances, early falls, vertical gaze palsy, rigidity, tremors, and cognitive decline, but it progresses ...

GemVax’s phase 2a study ran for 24 weeks and enrolled 78 patients with PSP across five centers in Korea. Patients received either placebo, GV1001 0.56 mg or GV1001 1.12 mg, the company said ...

SEOUL, South Korea, Oct. 29, 2024 /PRNewswire/ -- GemVax & KAEL Co., Ltd. ("GemVax"; KOSDAQ ticker: 082270) announced that topline results of a Phase 2a clinical trial (the "Phase 2a PSP Clinical ...

GemVax & KAEL Co., Ltd. ("GemVax"; KOSDAQ ticker: 082270) announced that topline results of a Phase 2a clinical trial (the "Phase 2a PSP Clinical Trial") of GV1001, an investigational peptide drug ...

GemVax & KAEL Co., Ltd. ("GemVax"; KOSDAQ ticker: 082270) announced that topline results of a Phase 2a clinical trial (the "Phase 2a PSP Clinical Trial") of GV1001, an investigational peptide drug for ...

A woman aged 60 years developed a Millard-Gubler syndrome after a diagnosis of a cavernous angioma in the median and paramedian areas of the pons. In this context, she presented a right VI nerve palsy ...

Medications and their Potential to Cause Increase 'Gaze palsy' Developed by - Dr. M. Janani Priya, Pharm D Reviewed by - Dr. M. Sree Mohana Preetha, Pharm D Last Updated on Nov 16, 2023 ...

Progressive supranuclear palsy (PSP) is a rare brain disorder that affects approximately 6 in 100,000 people worldwide. It is a rare disease that may appear similar to some other neurodegenerative ...